ALIA RIVAS: Open Payments
NPI 1386420552 · COPPERAS COVE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 31 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $797 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $94 |
| Lilly USA, LLC | 3 | $54 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Lundbeck LLC | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| ViiV Healthcare Company | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
Products named: Kerendia, REXULTI, Ozempic, TRELEGY ELLIPTA, Cologuard Collection Kit, XIFAXAN, MOUNJARO, CABENUVA.
Industry payments across TX — which companies pay providers there.
